IQV Stock — IQVIA Holdings Inc.

IQVIA Holdings Inc. (IQV)

Updated October 16, 2026.

IQV is a Stock. Total return is 533.8% over the past 13.4 years, 44.9 points ahead of SPY at 488.9%.

IQVIA Holdings Inc. is a Durham, North Carolina–based provider of clinical research services, commercial insights, and healthcare intelligence to life sciences and healthcare companies globally. The company operates three segments: Technology & Analytics Solutions, which offers cloud-based applications and real-world evidence generation; Research & Development Solutions, encompassing clinical trial support and laboratory services; and Contract Sales & Medical Solutions, providing provider and patient engagement services. The company does not currently have an established regular distribution schedule.

IQV performance versus SPY

Price and return data through 2026-10-16.

Total return is 533.8% over the past 13.4 years, 44.9 points ahead of SPY at 488.9%. Over the past year its total return — price change plus distributions reinvested — is 29.7%. Its deepest 1-year drawdown was 35.9%.

IQV key facts

Asset type

Stock

Asset class

Equity

Inception date

05/09/2013

Distribution frequency

None

Last close

$266.90 (as of 2026-10-16)

Market cap

$43,931,740,000

Average volume

1037033.0

Beta

1.186

Payout ratio

0.0%

P/E ratio

33.24

Forward P/E

18.4162

EPS

$8.03

How Dividend Vision calculates yield and returns

Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.

Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology

Sources and review

Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.

Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.

IQV risks and drawbacks

The deepest 1-year drawdown on record here is 35.9%.

Who may consider IQV — and who may not

It is a weaker fit for investors who need monthly cash flow (IQV does not currently distribute). This is educational context, not a recommendation to buy or sell.

More on IQV

• All tickers starting with I

Tagged: Healthcare.

Frequently asked questions